PsyPost
No Result
View All Result
PsyPost
No Result
View All Result
Home Exclusive Mental Health Addiction

Obscure psychedelic substance called ibogaine can help defeat drug addiction, study suggests

by Eric W. Dolan
October 4, 2014
in Addiction
Photo credit: Ashley Rose (Creative Commons)

Photo credit: Ashley Rose (Creative Commons)

Share on FacebookShare on Twitter

Could a mysterious hallucinogen used by shamans during healing ceremonies deep in the forests of Gabon be the key to defeating addiction? Though it sounds unlikely, preliminary research suggests a little-known psychedelic chemical called ibogaine could help people who abuse alcohol, cannabis, and cocaine overcome their substance dependence.

Ibogaine is one of the psychoactive chemicals found in the root bark of the African Tabernanthe iboga plant, which has been used in the shamanic rituals of the Bwiti religion in West Africa.

A team of researchers in Brazil has found that the use of ibogaine can facilitate prolonged periods of abstinence without serious complications when the drug is administered by a physician and accompanied with psychotherapy. Their findings were published September 29 in the Journal of Psychopharmacology.

In the early 1960s, anecdotal reports surfaced that ibogaine could help defeat opiate addiction, prompting some researchers to begin examining the anti-addictive properties of the drug. However, the investigation into ibogaine’s potential has been severely limited due to its illegal status in many countries.

“After these initial uncontrolled case reports, non-clinical, clinical and laboratory-based research has sought to assess ibogaine’s efficacy in the treatment of opioid addiction. At least two case studies have demonstrated the drug’s effectiveness at reducing cravings during opioid withdrawal: one from 32 patients treated at a clinic, and another from 33 patients treated in non-medical settings,” Eduardo Ekman Schenberg of the Federal University of Sao Paulo and his colleagues explained in their study.

Ibogaine has not been outlawed in Brazil, and the drug has been used to treat addiction since at least 2001. For their research, Schenberg and his colleagues investigated 75 drug-dependent patients who attended a private clinic that used a combination of ibogaine and cognitive-behavioral therapy to fight substance abuse.

Patients at the clinic — who suffered addictions to alcohol, cannabis, cocaine, and crack — were evaluated by multi-professional team of therapists and doctors before being administered ibogaine in a controlled setting.

The patients were administered ibogaine in the morning in a private hospital room, where they stayed overnight. The psychedelic experience lasted approximately 10 hours, and the patients were provided with psychological or emotional support if needed.

“This typically involved reassuring clients that all effects and reactions were part of the experience. Patients were encouraged to be quiet, calm and confident,” the researchers explained.

After their psychedelic experience, the patient continued receiving psychotherapy from the clinic, and were sometimes given another dose of ibogaine in the months following the first session.

The patients reported “surprisingly long periods of abstinence,” the researchers remarked, “reaching a median of 5.5 months after the first ibogaine session and 8.4 months after all subsequent ibogaine sessions.”

The eight women in the study all “reported that they were abstinent at the time of contact, and only two reported having had a relapse after the initial ibogaine session,” Schenberg and his colleagues wrote. “Both of these women then took ibogaine a second time and have reportedly not relapsed since.”

A majority of the men in the study, 58 of the 67, also stated that they were abstinent, “but 10 of those were currently undergoing other treatment interventions,” the researchers said. “Except for those 10, 38 (57%) men achieved abstinence with no other treatments.”

None of the patients report serious adverse effects, but many of them did report mild adverse reactions to ibogaine such as nausea, ataxia, vomiting, tremors, headaches and mental confusion.

Though the results seem promising, Schenberg and his colleagues cautioned that more rigorous scientific research is needed before ibogaine becomes an accepted treatment.

“Indeed, only a randomized double-blind clinical trial could accurately assess” the true potential of ibogaine as a treatment for drug addiction, they wrote.

“Despite the limitations of the present report, outlined above, the present data are the first formal clinical report to our knowledge that suggests that ibogaine has a strong therapeutic potential in the treatment of dependence to stimulants and other non-opiate drugs and that the medical complications previously reported can be avoided by administering the compound in the presence of a physician in a safe and legal medical setting,” the researchers concluded.

ShareTweetSendScanShareSharePinSend

Get all the latest updates on new psychology research with the free PsyPost app.
 


NEWSLETTER SIGN-UP

STAY CONNECTED

TRENDING

New study suggests that psychopathic individuals tend to become even worse after age 50

Biden voters were much more likely to report negative voting than Trump voters in the 2020 election

People with borderline tendencies have a higher number of estranged relationships

Women withhold honest sexual communication to protect their partner’s perceived masculinity, study finds

Partners’ heart rates synchronize in complex patterns of interaction when they are in close proximity

New research links deepfake pornography to psychopathic tendencies

RECENT

Reality TV viewing is associated with increased support for traditional gender roles among adolescents

Men who pose shirtless on Tinder are perceived as less competent and more prone to risky sexual behavior

Social media helps improve mood among older adults by enriching their in-person encounters, study suggests

Biden voters were much more likely to report negative voting than Trump voters in the 2020 election

Women withhold honest sexual communication to protect their partner’s perceived masculinity, study finds

  • Cognitive Science
  • COVID-19
  • Mental Health
  • Social Psychology
  • Drug Research
  • Conspiracy Theories
  • Meditation
  • Psychology of Religion
  • Aviation Psychology and Human Factors
  • Relationships and Sexual Health
Powered by

About

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Contact us
  • Privacy policy

No Result
View All Result
  • About
    • Newsletter signup form
  • Cart
  • Checkout
  • Contact
  • Contact us
  • My account
  • Privacy policy
  • Psychology news
  • PsyPost app privacy policy
  • Shop
  • SmartMag Home

This website uses cookies. By continuing to use this website you are giving consent to cookies being used.